Form 4 for DFTX Definium Therapeutics, Inc.
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-27 · accession 0001209191-22-032973 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-31 | 2022-05-27 | DFTX | Karlin Dan | Chief Medical Off | S - Sale | $0.82 | -9,555 | 4.08M | -0.2% | -$7,835 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2022-05-27 | S | D | 9,555 | $0.82 | 4,077,719 | D | — | — | (F2) The Subordinate Voting Shares were sold in one transaction at a price of $1.05 CAD dollars to cover payroll taxes. This represents the price in U.S. Dollars using the conversion rate on May 27, 2022. |